Rahmi Aslan et al. 2023. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology. 34, 3 (Mar. 2023), 310–310.